Louis Drapeau - Net Worth and Insider Trading

Louis Drapeau Net Worth

The estimated net worth of Louis Drapeau is at least $94,993 dollars as of 2024-12-24. Louis Drapeau is the Vice President and CFO of InSite Vision Inc and owns about 260,000 shares of InSite Vision Inc (INSV) stock worth over $90,350. Louis Drapeau is the Sr. VP Finance, CFO of Nektar Therapeutics and owns about 5,000 shares of Nektar Therapeutics (NKTR) stock worth over $4,501. Louis Drapeau is also the Director of Armata Pharmaceuticals Inc and owns about 71 shares of Armata Pharmaceuticals Inc (ARMP) stock worth over $143. Details can be seen in Louis Drapeau's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louis Drapeau has not made any transactions after 2015-10-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Louis Drapeau

To

Louis Drapeau Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Louis Drapeau owns 6 companies in total, including Armata Pharmaceuticals Inc (ARMP) , InSite Vision Inc (INSV) , and Bionovo Inc (BNVIQ) among others .

Click here to see the complete history of Louis Drapeau’s form 4 insider trades.

Insider Ownership Summary of Louis Drapeau

Ticker Comapny Transaction Date Type of Owner
ARMP Armata Pharmaceuticals Inc 2015-10-06 director
INSV InSite Vision Inc 2015-11-02 Vice President and CFO
BNVIQ Bionovo Inc 2011-05-10 director
LIMIT LIMIT 2007-03-05 Sr. VP Finance & CFO
LIMIT LIMIT 2007-02-14 director
LIMIT LIMIT 2003-11-03 CFO & Vice President & Finance

Louis Drapeau Latest Holdings Summary

Louis Drapeau currently owns a total of 3 stocks. Among these stocks, Louis Drapeau owns 260,000 shares of InSite Vision Inc (INSV) as of July 18, 2011, with a value of $90,350 and a weighting of 95.11%. Louis Drapeau owns 5,000 shares of Nektar Therapeutics (NKTR) as of March 5, 2007, with a value of $4,501 and a weighting of 4.74%. Louis Drapeau also owns 71 shares of Armata Pharmaceuticals Inc (ARMP) as of October 6, 2015, with a value of $143 and a weighting of 0.15%.

Latest Holdings of Louis Drapeau

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INSV InSite Vision Inc 2011-07-18 260,000 0.35 90,350
NKTR Nektar Therapeutics 2007-03-05 5,000 0.90 4,501
ARMP Armata Pharmaceuticals Inc 2015-10-06 71 2.01 143

Holding Weightings of Louis Drapeau


Louis Drapeau Form 4 Trading Tracker

According to the SEC Form 4 filings, Louis Drapeau has made a total of 0 transactions in InSite Vision Inc (INSV) over the past 5 years. The most-recent trade in InSite Vision Inc is the acquisition of 200,000 shares on July 18, 2011, which cost Louis Drapeau around $120,000.

According to the SEC Form 4 filings, Louis Drapeau has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the acquisition of 1,000 shares on March 5, 2007, which cost Louis Drapeau around $11,770.

According to the SEC Form 4 filings, Louis Drapeau has made a total of 0 transactions in Armata Pharmaceuticals Inc (ARMP) over the past 5 years. The most-recent trade in Armata Pharmaceuticals Inc is the acquisition of 71 shares on October 6, 2015, which cost Louis Drapeau around $43,900.

Insider Trading History of Louis Drapeau

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Louis Drapeau Trading Performance

GuruFocus tracks the stock performance after each of Louis Drapeau's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis Drapeau is -13.71%. GuruFocus also compares Louis Drapeau's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis Drapeau within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Louis Drapeau's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Louis Drapeau

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Louis Drapeau Ownership Network

Ownership Network List of Louis Drapeau

No Data

Ownership Network Relation of Louis Drapeau

Insider Network Chart

Louis Drapeau Owned Company Details

What does Armata Pharmaceuticals Inc do?

Who are the key executives at Armata Pharmaceuticals Inc?

Louis Drapeau is the director of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .

Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Armata Pharmaceuticals Inc Insider Transactions

No Available Data

Louis Drapeau Mailing Address

Above is the net worth, insider trading, and ownership report for Louis Drapeau. You might contact Louis Drapeau via mailing address: C/o Biomarin Pharmaceutical Inc., 371 Bel Marin Keys Blvd., Suite 210, Novato Ca 94949.

Discussions on Louis Drapeau

No discussions yet.